News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
18,058 Results
Type
Article (488)
Company Profile (1)
Press Release (17569)
Section
Business (9832)
Career Advice (22)
Deals (1265)
Drug Development (1515)
FDA (354)
Job Trends (474)
News (12245)
Policy (601)
Tag
Academia (41)
Accelerated approval (2)
Allergies (5)
Alliances (539)
ALS (5)
Alzheimer's disease (25)
Antibody-drug conjugate (ADC) (8)
Approvals (388)
Artificial intelligence (7)
Autoimmune disease (2)
Automation (2)
Bankruptcy (5)
Best Places to Work (476)
Biosimilars (6)
Biotechnology (2)
Bladder cancer (9)
Breast cancer (32)
Cancer (133)
Cardiovascular disease (29)
Career advice (19)
CAR-T (4)
Cell therapy (13)
Cervical cancer (2)
Clinical research (1465)
Collaboration (20)
Compensation (15)
COVID-19 (31)
CRISPR (3)
C-suite (2)
Cystic fibrosis (1)
Data (220)
Depression (4)
Dermatology (1)
Diabetes (18)
Diagnostics (284)
Digital health (2)
Drug discovery (2)
Drug pricing (1)
Duchenne muscular dystrophy (6)
Earnings (9926)
Events (1418)
Executive appointments (3)
FDA (540)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (10)
Gene editing (5)
Generative AI (2)
Gene therapy (13)
GLP-1 (29)
Government (74)
Guidances (118)
Healthcare (714)
HIV (1)
Huntington's disease (1)
IgA nephropathy (6)
Immunology and inflammation (11)
Immuno-oncology (1)
Indications (4)
Infectious disease (36)
Inflammatory bowel disease (3)
Influenza (1)
Intellectual property (2)
Interviews (2)
IPO (1052)
Job creations (29)
Job search strategy (16)
Labor market (2)
Layoffs (19)
Legal (102)
Liver cancer (5)
Lung cancer (8)
Lymphoma (14)
Manufacturing (10)
MASH (5)
Medical device (806)
Medtech (812)
Mergers & acquisitions (221)
Metabolic disorders (34)
mRNA (2)
Multiple sclerosis (4)
NASH (1)
Neurodegenerative disease (5)
Neuropsychiatric disorders (2)
Neuroscience (64)
NextGen: Class of 2026 (165)
Non-profit (102)
Obesity (12)
Opinion (1)
Ovarian cancer (1)
Pain (2)
Pancreatic cancer (3)
Parkinson's disease (2)
Patents (3)
Patient recruitment (6)
Peanut (2)
People (488)
Pharmacy benefit managers (1)
Phase 1 (293)
Phase 2 (539)
Phase 3 (714)
Pipeline (571)
Postmarket research (51)
Preclinical (92)
Press Release (1)
Prostate cancer (3)
Radiopharmaceuticals (4)
Rare diseases (18)
Real estate (56)
Regulatory (524)
Reports (4)
Research institute (55)
Resumes & cover letters (3)
Rett syndrome (2)
RSV (2)
Schizophrenia (15)
Sickle cell disease (5)
Special edition (1)
Spinal muscular atrophy (9)
Sponsored (3)
Startups (28)
Supply chain (1)
Vaccines (6)
Weight loss (9)
Women's health (7)
Date
Last 7 days (18)
Last 30 days (128)
Last 365 days (1147)
2026 (307)
2025 (1158)
2024 (1382)
2023 (1588)
2022 (1702)
2021 (1915)
2020 (1765)
2019 (1207)
2018 (2936)
2017 (509)
2016 (286)
2015 (429)
2014 (322)
2013 (123)
2012 (236)
2011 (277)
2010 (279)
Location
Africa (10)
Alabama (1)
Arizona (6)
Asia (952)
Australia (73)
California (474)
Canada (146)
China (27)
Colorado (26)
Connecticut (42)
Delaware (21)
Europe (2261)
Florida (65)
Georgia (15)
Idaho (1)
Illinois (38)
India (6)
Indiana (42)
Japan (11)
Kansas (1)
Kentucky (3)
Louisiana (6)
Maine (5)
Maryland (52)
Massachusetts (288)
Michigan (11)
Minnesota (33)
Missouri (4)
Montana (1)
Nevada (1)
New Hampshire (5)
New Jersey (187)
New York (104)
North Carolina (121)
Northern California (267)
Ohio (11)
Pennsylvania (93)
Rhode Island (1)
South America (15)
Southern California (173)
Tennessee (3)
Texas (51)
United States (1759)
Utah (20)
Virginia (3)
Washington D.C. (2)
Washington State (34)
Wisconsin (5)
18,058 Results for "183".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer
October 23, 2025
·
4 min read
Press Releases
Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 16, 2025
·
6 min read
Press Releases
Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 21, 2025
·
7 min read
Digital Health Market to Expand at 18.3% CAGR During 2021-2028, Increase in Adoption of Digital Health Products by Health Care Providers to Drive the Market
Wilmington, Delaware, United States: According to the report, the global digital health market was valued at US$ 307.7 Bn in 2020 and is projected to expand at a CAGR of 18.3% from 2021 to 2028.
June 9, 2022
·
6 min read
Nanotechnology Market Size to Reach USD 290.93 Billion in 2028 Growing at a CAGR of 18.3%, according to Emergen Research
According to Emergen Research, the global nanotechnology market size was USD 75.80 Billion in 2020 and is expected to reach USD 290.93 Billion in 2028 and register a revenue CAGR of 18.3% during the forecast period, 2021-2028.
December 22, 2021
·
7 min read
Plasmid DNA Manufacturing Market Size to Increase USD 12.36 billion by 2033
According to Vision Research Reports, the global plasmid DNA manufacturing market size was estimated at USD 1.83 billion in 2023
April 16, 2024
·
9 min read
SAB Biotherapeutics Announces First Publication of Promising Nonclinical Data for SAB-183 Against Pneumonic Plague in the Journal Antibodies
SAB Biotherapeutics (Nasdaq: SABS), (SAB) today announced the publication of nonclinical data in the medical journal Antibodies.
May 12, 2023
·
6 min read
Biotech Beach
GRI Bio Announces Pricing of $4 Million Public Offering
GRI Bio, Inc. announced the pricing of a public offering of an aggregate of 2,185,793 shares of its common stock, Series C-1 warrants to purchase up to 2,185,793 shares of common stock and Series C-2 warrants to purchase up to 2,185,793 shares of common stock, at a combined public offering price of $1.83 per share and accompanying Series Warrants.
June 27, 2024
·
6 min read
Biotech Beach
GRI Bio Announces Closing of $4.0 Million Public Offering
GRI Bio, Inc. announced the closing of its previously announced public offering for the purchase and sale of an aggregate of 2,185,793 shares of its common stock, Series C-1 warrants to purchase up to 2,185,793 shares of common stock and Series C-2 warrants to purchase up to 2,185,793 shares of common stock, at a combined purchase price of $1.83 per share and accompanying Series Warrants.
June 28, 2024
·
6 min read
Press Releases
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - March 23, 2026
March 23, 2026
·
2 min read
1 of 1,806
Next